Search Within

Sean McCarthy Devlin

  1. "2016"
Formats
  1. Meeting Abstract (44)
  2. Journal Article (20)
Groups
  1. Biostatistics Service (64)
  2. Epidemiology and Biostatistics (64)
  3. Department of Medicine (60)
  4. Hematologic Malignancies, Division of (60)
  5. Center for Hematologic Malignancies (59)
  6. Bone Marrow Transplant (45)

More Groups

People
  1. Sergio Giralt (37)
  2. Miguel-Angel Perales (33)
  3. Hugo Castro-Malaspina (23)
  4. Molly Maloy (19)
  5. Ann Jakubowski (18)
  6. Doris Ponce (18)

More People

Years
  1. 2016 (64)
Publications
  1. Biology of Blood and Marrow Transplantation (16)
  2. Bone Marrow Transplantation (15)
  3. Blood (14)
  4. British Journal of Haematology (2)
  5. Haematologica (2)
  6. Journal of Clinical Oncology (2)

More Publications

Publishers
  1. Nature Publishing Group (17)
  2. Elsevier Inc. (16)
  3. American Society of Hematology (14)
  4. American Society of Clinical Oncology (2)
  5. Elsevier Ltd (2)
  6. Ferrata Storti Foundation (2)

More Publishers

Results (64)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prevalence of clonal hematopoiesis in patients with advanced cancer
    Meeting Abstract

    Zehir, A.; Coombs, C. C.; Devlin, S.; Kishtagari, A.; Hyman, D. M.; Solit, D. B.; Robson, M. E.; Baselga, J.; Arcila, M. E.; Tallman, M. S.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Outcomes of patients 60 and older with ALL: Analysis of the SEER database
    Meeting Abstract

    Geyer, M. B.; Hsu, M.; Devlin, S.; Douer, D.; Park, J. H.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Intestinal microbiota and relapse after hematopoietic-cell transplantation
    Meeting Abstract

    Peled, J.; Devlin, S.; Staffas, A.; Lumish, M.; Rodriguez, K. P.; Ahr, K.; Perales, M.; Giralt, S.; Taur, Y.; Pamer, E.; more...
    Journal for ImmunoTherapy of Cancer (2016)

    Fulltext@MSK | Save
  • Comparable survival and incidence of toxicity for older adult patients after CD34+ selected allogeneic hematopoietic stem cell transplantation
    Meeting Abstract

    Shah, G. L.; Scordo, M.; Kosuri, S.; Herrera, D. A.; Maloy, M. A.; Nieves, J.; Devlin, S.; Borrill, T.; Avecilla, S. T.; Meagher, R. C.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Multicolor flow cytometry and multi-gene next generation sequencing are complimentary and highly predictive for relapse in acute myeloid leukemia following allogeneic hematopoietic stem cell transplant
    Meeting Abstract

    Getta, B. M.; Devlin, S.; Maloy, M. A.; Mohanty, A.; Arcila, M.; Tallman, M. S.; Levine, R. L.; Giralt, S. A.; Roshal, M.
    Blood (2016)

    Fulltext@MSK | Save
  • Mutational analysis of clonal hematopoiesis in solid tumor patients illustrates the critical role of systemic anti-cancer therapies in the evolution of somatic leukemia disease alleles
    Meeting Abstract

    Coombs, C. C.; Zehir, A.; Devlin, S.; Kishtagari, A.; Hyman, D. M.; Solit, D.; Robson, M.; Baselga, J.; Arcila, M.; Tallman, M. S.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Despite increasing size of unrelated donor (URD) registries and the global cord blood (CB) inventory racial disparities in access to URD and CB grafts persist: A prospective 10 year analysis of 1,112 patients
    Meeting Abstract

    Boughan, K.; Dahi, P. B.; Devlin, S.; Byam, C.; Yoo, Y.; Mazis, C.; Davis, E.; Nhaissi, M.; Paulson, J.; Wells, D.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • A comprehensive analysis of late toxicities and associated risk factors in long-term survivors of myeloablative conditioned allogeneic hematopoietic cell transplantation using ex-vivo CD34+ selection-based graft-versus-host disease prophylaxis
    Meeting Abstract

    Scordo, M.; Shah, G. L.; Kosuri, S.; Herrera, D. A.; Devlin, S.; Maloy, M. A.; Nieves, J.; Borrill, T.; Avecilla, S. T.; Meagher, R. C.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • A pediatric-inspired regimen containing multiple doses of intravenous pegylated asparaginase appears safe and effective in newly diagnosed adult patients with Ph-negative acute lymphoblastic leukemia in adults up to age 60: Results of a multi-center phase II clinical trial
    Meeting Abstract

    Park, J. H.; Ritchie, E. K.; Rao, A. V.; Devlin, S.; Hsu, M.; Khawaja, T. T.; O'Donnell, B. A.; Cazacu, M. I.; Stopka, D. M.; Tallman, M. S.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Impact of treatment center characteristics on early death rates in patients with newly diagnosed acute promyelocytic leukemia: Analysis of data from the SEER program
    Meeting Abstract

    Park, J. H.; Devlin, S.; Lynch, C.; Schwartz, A.; Keegan, T.; Gonsalves, L.; Hermit, K.; Green, M.; Douer, D.; Tallman, M. S.
    Blood (2016)

    Fulltext@MSK | Save